Why is "Anticalin" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-26 12:48:33
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Anticalin entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-26 and was most recently seen on 2026-05-26.
Wikipedia Overview
Anticalin proteins are artificial proteins that are able to bind to antigens, either to proteins or to small molecules. They are not structurally related to antibodies, which makes them a type of antibody mimetic. Instead, they are derived from human lipocalins which are a family of naturally binding proteins. Anticalin proteins are being used in lieu of monoclonal antibodies, but are about eight times smaller with a size of about 180 amino acids and a mass of about 20 kDa.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
β-amyloid monomer scavenging by an anticalin protein prevents neuronal hyperactivity in mouse models of Alzheimer’s Disease - Nature
-
Pulmonary-delivered Anticalin Jagged-1 antagonists reduce experimental airway mucus hyperproduction and obstruction - American Physiological Society Journal
-
Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM - Nature
-
AstraZeneca and Pieris Pharmaceuticals collaborate to develop and commercialise Anticalin-based inhaled treatments for respiratory diseases - AstraZeneca
-
Pieris loses Servier as partner for cancer immunotherapies - pharmaphorum
-
A new Anticalin protein for IL-23 inhibits non-type 2 allergen-driven mouse lung inflammation and airway hyperresponsiveness - American Physiological Society Journal
-
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials - SciTechDaily
-
PIRS: In Vivo Preclinical Data on PRS-343 to be Presented at AACR 2016… - scr.zacks.com
-
AstraZeneca Halts Phase II Asthma Trial Due to Safety Findings in Toxicology Study - BioSpace
-
Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific - Business Wire
-
Double-Barreled Antibodies - Genetic Engineering and Biotechnology News
-
Revolutionary treatment could stop and reverse early-stage Alzheimer’s - The Brighter Side of News
-
Tracking immune cells inside the body - TUM
-
Pieris wields axe after losing AZ as partner for elarekibep - pharmaphorum
-
PET-based tracking of CAR T cells and viral gene transfer using a cell surface reporter that binds to lanthanide complexes - Nature
-
PIRS: Positive Preclinical Data Presented for PRS-343 - scr.zacks.com
-
Zydus joins hands with Pieris for drug development - The Hindu
-
Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.